Regeneron has signed a collaboration deal ... with the lead party retaining global development and commercial responsibility. For CNS programs, both companies will have the option at candidate ...
NEW YORK, Jan 13 (Reuters) - Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals (REGN.O), opens new tab, Illumina (ILMN.O), opens new ...
Biotech company Regeneron (NASDAQ:REGN) reported Q4 CY2024 results topping the market’s revenue expectations , with sales up 10.3% year on year to $3.79 billion. Its non-GAAP profit of $12.07 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback